|
![]() |
|
|
|
|
» Apply for a Grant
- FAQs - Young Investigator - Independent Investigator - Distinguished Investigator - Staglin Award » Grantee List - Young Investigators - Independent Investigators - Distinguished Investigators - Staglin Awards
» Prizes
- Lieber Prize - Falcone Prize - Ruane Prize - Goldman-Rakic Prize - Freedman Award - Klerman Award » For Grantees - Young Investigator Fact Sheet - Independent Investigator Fact Sheet - Distinguished Investigator Fact Sheet - Staglin Award Fact Sheet
|
Mary C. Zanarini, EDD (Independent Investigator 2000) of McLean Hospital, is conducting a double-blind placebo controlled trial of omega-3 fatty acids in borderline personality disorder. This disorder is a relatively common and severe psychiatric disorder characterized by intense feelings of unhappiness, severe mood swings, and self-destructive behaviors. Omega-3 fatty acids (a type of fish oil) appear to have mood-stabilizing and mood-elevating properties. In the present study, it is therefore hypothesized that omega-3 fatty acids will diminish the depression and mood swings found in borderline personality disorder. This work may lead to a promising new treatment of this disorder. Program Area: PERSONALITY DISORDERS\Borderline Personality Disorder |
Announcements
NARSAD Award Winners
Latest News from NARSAD
|